C-Path Partners with Unite4TB to Create a New Dawn in the Fight Against Tuberculosis C-Path is proud to be part of UNITE4TB, a public-private partnership funded by the Innovative Medicines Initiative and part of the
November 7, 2023 C-Path’s T1D Consortium New-onset Article Published in The Lancet Diabetes and Endocrinology ype 1 Diabetes Consortium, along with external collaborators from Cardiff University and the University of Alberta, today announce
ASN PKDOC Poster — November 2023: Despite the regulatory advances in ADPKD including the qualification of total kidney volume (TKV) as a prognostic enrichment bioma
eCOA Consortium Announces Publication of an Open Access Article C-Path’s eCOA Consortium is pleased to announce the publication of an open access article in Value in Health titled “Best Prac
October 26, 2023 C-Path and Congenital Hyperinsulinism International Announce Data Sharing Agreement TUCSON, Ariz., October 26, 2023 — Critical Path Institute (C-Path) and Congenital Hyperinsulinism International (CHI), a leading
October 25, 2023 C-Path Announces Significant Expansion in Neonatal RWD Project Details of the expansion will be a highlight of the Institute’s Scientific Breakthrough Summit Oct. 26-27 in D.C. TUCSON, Ariz.,
November 21, 2023 Use of Registries in Regulatory Decision Making The C-Path team is working to revolutionize the use of real-world data in sharing the future of medical product development in...
Critical Path for Parkinson’s Welcomes New Co-chairs Pagano, Gaetano Critical Path for Parkinson’s mission is to serve as a leading international consortium convening diverse stakeholders to
October 16, 2023 Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area Workshop Neurological disorders represent some of the most challenging therapeutic areas for successful drug approvals.
October 11, 2023 Applying propensity methods to the United States transplant registry for external real-world evidence control arms for 5-year survival in the BENEFIT study To address the challenges of assessing the impact of a reasonably likely surrogate endpoint on long-term graft survival....